These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25171703)

  • 1. Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow.
    Jabbar KJ; Medeiros LJ; Wang SA; Miranda RN; Johnson MR; Verstovsek S; Jorgensen JL
    Arch Pathol Lab Med; 2014 Sep; 138(9):1210-4. PubMed ID: 25171703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis.
    Nwogbo OV; Fang H; Wang W; Xu J; Miranda RN; Bose P; Ok CY; Jorgensen JL; Medeiros LJ; Wang SA
    Am J Clin Pathol; 2024 Jun; 161(6):598-608. PubMed ID: 38372648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis.
    Cherian S; McCullouch V; Miller V; Dougherty K; Fromm JR; Wood BL
    Cytometry B Clin Cytom; 2016 Jul; 90(4):387-92. PubMed ID: 26525770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.
    Morgado JM; Sánchez-Muñoz L; Teodósio CG; Jara-Acevedo M; Alvarez-Twose I; Matito A; Fernández-Nuñez E; García-Montero A; Orfao A; Escribano L
    Mod Pathol; 2012 Apr; 25(4):516-21. PubMed ID: 22222639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
    Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.
    Chisholm KM; Merker JD; Gotlib JR; Gitana G; Lefterova M; Zehnder JL; George TI; Arber DA; Ohgami RS
    Am J Clin Pathol; 2015 Apr; 143(4):527-34. PubMed ID: 25780004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement.
    Pozdnyakova O; Kondtratiev S; Li B; Charest K; Dorfman DM
    Am J Clin Pathol; 2012 Sep; 138(3):416-24. PubMed ID: 22912359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry.
    Baumgartner C; Sonneck K; Krauth MT; Kneidinger M; Födinger M; Hauswirth AW; Müllauer L; Valent P
    Eur J Clin Invest; 2008 May; 38(5):326-35. PubMed ID: 18363719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis.
    Trindade CJ; Sun X; Maric D; Sharma S; Komarow HD; Hourigan CS; Klion A; Maric I
    Cytometry B Clin Cytom; 2024 Sep; 106(5):370-382. PubMed ID: 38666394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotyping of mast cells: a sensitive and specific diagnostic tool for systemic mastocytosis.
    van Daele PL; Beukenkamp BS; Geertsma-Kleinekoort WM; Valk PJ; van Laar JA; van Hagen PM; van der Velden VH
    Neth J Med; 2009 Apr; 67(4):142-6. PubMed ID: 19581658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
    Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
    Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders.
    Perbellini O; Zamò A; Colarossi S; Zampieri F; Zoppi F; Bonadonna P; Schena D; Artuso A; Martinelli G; Chilosi M; Pizzolo G; Zanotti R
    Cytometry B Clin Cytom; 2011 Nov; 80(6):362-8. PubMed ID: 21656905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
    Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
    Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).
    Escribano L; Diaz-Agustin B; López A; Núñez López R; García-Montero A; Almeida J; Prados A; Angulo M; Herrero S; Orfao A;
    Cytometry B Clin Cytom; 2004 Mar; 58(1):1-8. PubMed ID: 14994369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.
    Akin C; Valent P; Escribano L
    Curr Allergy Asthma Rep; 2006 Jul; 6(4):282-8. PubMed ID: 16822380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients.
    Pardanani A; Kimlinger T; Reeder T; Li CY; Tefferi A
    Leuk Res; 2004 Aug; 28(8):777-83. PubMed ID: 15203275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis.
    Núñez-López R; Escribano L; Schernthaner GH; Prados A; Rodríguez-González R; Díaz-Agustín B; López A; Hauswirth A; Valent P; Almeida J; Bravo P; Orfao A
    Br J Haematol; 2003 Jan; 120(2):257-65. PubMed ID: 12542483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults.
    Escribano L; Díaz Agustín Beatriz ; Bravo P; Navalón R; Almeida J; Orfao A
    Leuk Lymphoma; 1999 Oct; 35(3-4):227-35. PubMed ID: 10706445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
    Escribano L; Díaz-Agustín B; Bellas C; Navalón R; Nuñez R; Sperr WR; Schernthaner GH; Valent P; Orfao A
    Leuk Res; 2001 Jul; 25(7):563-70. PubMed ID: 11377681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.